Sacral neuromodulation in pediatric bladder and bowel dysfunctions: Literature review

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND: Sacral neuromodulation is a neurosurgical method for the correction of bladder and bowel dysfunctions of various origins that are refractory to conservative treatment.

AIM: To analyze chronic sacral neurostimulation results as a correction method for pediatric bladder and bowel dysfunction of various origins.

MATERIALS AND METHODS: The results of chronic sacral neurostimulation for treating urination and defecation disorders of various origins in children reported in the world literature were analyzed. The literature search was performed in the open electronic scientific databases eLIBRARY, PubMed, and Cochrane Library. The source selection was limited by 2002–2022.

RESULTS: Most authors report good and satisfactory results in the treatment of bladder and bowel dysfunction by sacral neurostimulation. However, the level of evidence on the effectiveness of sacral neurostimulation remains low because data were obtained from small and heterogeneous groups of patients and studies employed different criteria for inclusion and methods for analyzing the results.

CONCLUSIONS: Conducting randomized trials will allow for the assessment of the efficacy and safety of sacral neuromodulation in children with bladder and bowel dysfunctions of various origins that are refractory to standard conservative treatment.

About the authors

Alina M. Khodorovskaya

H. Turner National Medical Research Center for Сhildren’s Orthopedics and Trauma Surgery

Author for correspondence.
Email: alinamyh@gmail.com
ORCID iD: 0000-0002-2772-6747
SPIN-code: 3348-8038

MD, Research Associate

Russian Federation, Saint Petersburg

Vladimir A. Novikov

H. Turner National Medical Research Center for Сhildren’s Orthopedics and Trauma Surgery

Email: novikov.turner@gmail.com
ORCID iD: 0000-0002-3754-4090
Scopus Author ID: 57193252858

MD, PhD, Cand. Sci. (Med.)

Russian Federation, Saint Petersburg

Alexey V. Zvozil

H. Turner National Medical Research Center for Children's Orthopedics and Trauma Surgery

Email: zvosil@mail.ru
ORCID iD: 0000-0002-5452-266X

MD, PhD, Cand. Sci. (Med.)

Russian Federation, Saint-Petersburg

Valery V. Umnov

H. Turner National Medical Research Center for Сhildren’s Orthopedics and Trauma Surgery

Email: umnovvv@gmail.com
ORCID iD: 0000-0002-5721-8575

MD, PhD, Dr. Sci. (Med.)

Russian Federation, Saint Petersburg

Dmitry V. Umnov

H. Turner National Medical Research Center for Сhildren’s Orthopedics and Trauma Surgery

Email: dmitry.umnov@gmail.com
ORCID iD: 0000-0003-4293-1607

MD, PhD, Cand. Sci. (Med.)

Russian Federation, Saint Petersburg

Dmitry S. Zharkov

H. Turner National Medical Research Center for Сhildren’s Orthopedics and Trauma Surgery

Email: striker5621@gmail.com
ORCID iD: 0000-0002-8027-1593

MD

Russian Federation, Saint Petersburg

Sergei V. Vissarionov

H. Turner National Medical Research Center for Сhildren’s Orthopedics and Trauma Surgery

Email: vissarionovs@gmail.com
ORCID iD: 0000-0003-4235-5048
SPIN-code: 7125-4930
Scopus Author ID: 6504128319
ResearcherId: P-8596-2015

MD, PhD, Dr. Sci. (Med.), Professor, Corresponding Member of RAS

Russian Federation, Saint Petersburg

References

  1. Vaz GT, Vasconcelos MM, Oliveira EA, et al. Prevalence of lower urinary tract symptoms in school-age children. Pediatric Nephrology. 2012;27(4):597–603. doi: 10.1007/s00467-011-2028-1
  2. Sampaio C, Sousa AS, Fraga LG, et al. Constipation and lower urinary tract dysfunction in children and adolescents: a population-based study. Front Pediatr. 2016;4:101. doi: 10.3389/fped.2016.00101
  3. Sumboonnanond A, Sawangsuk P, Sungkabuth P, et al. Screening and management of bladder and bowel dysfunction in general pediatric outpatient clinic: a prospective observational study. BMC Pediatr. 2022;22:288. doi: 10.1186/s12887-022-03360-9
  4. Yüksel S, Yurdakul AÇ, Zencir M, et al. Evaluation of lower urinary tract dysfunction in Turkish primary schoolchildren: an epidemiological study. J Pediatr Urol. 2014;10(6):1181–1186. doi: 10.1016/j.jpurol.2014.05.008
  5. Austin PF, Bauer SB, Bower W, et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children’s Continence Society. Neurourol Urodyn. 2016;35(4):471–481. doi: 10.1002/nau.22751
  6. Lai HH, Shen B, Rawal A, et al. The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population. BMC Urol. 2016;16:60. doi: 10.1186/s12894-016-0179-x
  7. Collis D, Kennedy-Behr A, Kearney L. The impact of bowel and bladder problems on children’s quality of life and their parents: a scoping review. Child Care Health Dev. 2019;45(1):1–14. doi: 10.1111/cch.12620
  8. Santos JD, Lopes RI, Koyle MA. Bladder and bowel dysfunction in children: an update on the diagnosis and treatment of a common, but underdiagnosed pediatric problem. Can Urol Assoc J. 2017;11:S64–S72. doi: 10.5489/cuaj.4411
  9. Caldwell KPS. The electrical control of sphincter incompetence. Lancet. 1963;282:174–175. doi: 10.1016/s0140-6736(63)92807-1
  10. Abello A, Das AK. Electrical neuromodulation in the management of lower urinary tract dysfunction: evidence, experience and future prospects. Ther Adv Urol. 2018;10(5):165–173. DOI: 10.1177/ 1756287218756082
  11. Szymański JK, Słabuszewska-Jóźwiak A, Zaręba K, et al. Neuromodulation — a therapeutic option for refractory overactive bladder: a recent literature review. Videosurgery and Other Miniinvasive Techniques. 2019;14(4):476–485. doi: 10.5114/wiitm.2019.85352
  12. Mass-Lindenbaum M, Calderón-Pollak D, Goldman HB, et al. Sacral neuromodulation — when and for who. Int Braz J Urol. 2021;47(3):647–656. doi: 10.1590/S1677-5538.IBJU.2021.99.08
  13. Tanagho EA, Schmidt RA. Bladder pacemaker: scientific basis and clinical future. Urology. 1982;20(6):614–619. doi: 10.1016/0090-4295(82)90312-0
  14. Vaganee D, Fransen E, Voorham J, et al. Behind the scenes: an electromyographic interpretation of the pelvic floor contractions seen by the naked eye upon lead stimulation in sacral neuromodulation patients [Abstract]. Neurourol Urodyn. 2019;38:S446–S448.
  15. Gill BC, Pizarro-Berdichevsky J, Bhattacharyya PK, et at. Real-time changes in brain activity during sacral neuromodulation for overactive bladder. J Urol. 2017;198:1379–1385. doi: 10.1016/j.juro.2017.06.074
  16. De Wachter S, Vaganee D, Kessler TM. Sacral neuromodulation: mechanism of action. Eur Urol Focus. 2020;6(5):823–825. doi: 10.1016/j.euf.2019.11.018
  17. Strine AC, Keenan AC, King S, et al. Sacral neuromodulation in children. Current Bladder Dysfunction Reports. 2015;10(4):332–337. doi: 10.1007/s11884-015-0322-7
  18. Goldman HB., Lloyd JC, Noblett KL, et al. International continence society best practice statement for use of sacral neuromodulation. Neurourol Urodyn. 2018;37(5):1823–1848. doi: 10.1002/nau.23515
  19. Beloy C, García-Novoa MA, Argibay S, et al. Update on sacral neuromodulation and overactive bladder in pediatrics: a systematic review. Archivos Espanoles de Urologia. 2021;74(7):699–708. doi: 10.37554/en-20210307-3421-5
  20. Dekopov AV, Tomskiy AA, Isagulyan ED, et al. Chronic sacral neuromodulation for pelvic floor dysfunction in children with spina bifida. Burdenko’s Journal of Neurosurgery. 2022;86(1):48–55. (In Russ.). doi: 10.17116/neiro20228601148
  21. Hoebeke P, Van Laecke E, Everaert K, et al. Transcutaneous neuromodulation for the urge syndrome in children: a pilot study. J Urol. 2001;166(6):2416–2419. doi: 10.1016/S0022-5347(05)65605-4
  22. Butrick CW. Patient selection for sacral nerve stimulation. Int Urogynecol J. 2010:S447-S451. doi: 10.1007/s00192-010-1274-2
  23. Dwyer ME, Vandersteen DR, Hollatz P, et al. Sacral neuromodulation for the dysfunctional elimination syndrome: a 10-year single-center experience with 105 consecutive children. Urology. 2014;84:911–918. doi: 10.1016/j.urology.2014.03.059
  24. Fuchs ME, Lu PL, Vyrostek SJ, et al. Factors predicting complications after sacral neuromodulation in children. Urology. 2017;107:214–217. doi: 10.1016/j.urology.2017.05.014
  25. Rensing AJ, Szymanski KM, Dunn S, et al. Pediatric sacral nerve stimulator explanation due to complications or cure: a survival analysis. J Pediatr Urol. 2019;15(1):e1–e6. doi: 10.1016/j.jpurol.2018.10.010
  26. Pellegrino C, Bershadskii A, Lena F, et al. Sacral neuromodulation in pediatric population: what we learned after 65 implants. Continence. 2022;2:1–2. doi: 10.1016/j.cont.2022.100438
  27. Guys JM, Haddad M, Planche D, et al. Sacral neuromodulation for neurogenic bladder dysfunction in children. J Urol. 2004;172:1673–1676. doi: 10.1097/01.ju.0000138527.98969.b0
  28. Haddad M, Besson R, Aubert D, et al. Sacral neuromodulation in children with urinary and fecal incontinence: a multicenter, open label, randomized, crossover study. J Urol. 2010:184:696–701. doi: 10.1016/j.juro.2010.03.054
  29. Lu PL, Koppen IJ, Yacob D, et al. The prognostic value of manometry testing in children with constipation treated with sacral nerve stimulation. J Pediatr Gastroenterol Nutr. 2016;63(Suppl 2):S97–S8.
  30. Schober MS, Sulkowski JP, Lu PL, et al. Sacral nerve stimulation for pediatric lower urinary tract dysfunction: development of a standardized pathway with objective urodynamic outcomes. J Urol. 2015;194(6):1721–1727. doi: 10.1016/j.juro.2015.06.090
  31. Groen LA, Hoebeke P, Loret N, et al. Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-year experience. J Urol. 2012;188:1313–1317. doi: 10.1016/j.juro.2012.06.039
  32. Mosiello G, Safder S, Marshall D. Neurogenic bowel dysfunction in children and adolescents. J Clin Med. 2021;10(8):1669. doi: 10.3390/jcm10081669
  33. Hiller SC, Schober MS. Pediatric sacral neuromodulation for voiding dysfunction. In: Adult and Pediatric Neuromodulation. Ed. by J. Gilleran, S. Alpert. 2018:233–236. doi: 10.1007/978-3-319-73266-4_17
  34. Mason MD, Stephany HA, Casella DP, et al. Prospective evaluation of sacral neuromodulation in children: outcomes and urodynamic predictors of success. J Urol. 2016;195:1239–1244. doi: 10.1016/j.juro.2015.11.034
  35. Chen G, Liao L, Deng H. The effect of sacral neuromodulation in ambulatory spina bifida patients with neurogenic bladder and bowel dysfunction. Urology. 2021;153:345–350. doi: 10.1016/j.urology.2020.11.075
  36. Van der Jagt PKN, Dik P, Froeling M, et al. Architectural configuration and microstructural properties of the sacral plexus: a diffusion tensor MRI and fiber tractography study. NeuroImage. 2012;62(3):1792–1799. doi: 10.1016/j.neuroimage.2012.06
  37. Sharifiaghdas F. Sacral neuromodulation in congenital lumbo-sacral and traumatic spinal cord defects with neurogenic lower urinary tract symptoms: a single-center experience in children and adolescents. World Journal of Urology. 2019;37(12):2775–2783. doi: 10.1007/s00345-019-02721-x
  38. Sievert KD, Amend B, Gakis G, et al. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann Neurol. 2010;67:74–84. doi: 10.1002/ana.21814
  39. Chen G, Liao L, Dong Q, et al. The inhibitory effects of pudendal nerve stimulation on bladder overactivity in spinal cord injury dogs: is early stimulation necessary? Neuromodulation. 2012;15:232–237. doi: 10.1111/j.1525-1403.2012.00434.x
  40. Lombardi G, Musco S, Celso M, et al. Intravesical electrostimulation versus sacral neuromodulation for incomplete spinal cord patients suffering from neurogenic non-obstructive urinary retention. Spinal Cord. 2013;51:571–578. doi: 10.1038/sc.2013.37
  41. Hu M, Lai S, Zhang Y, et al. Sacral neuromodulation for lower urinary tract dysfunction in spinal cord injury: a systematic review and meta-analysis. Urol Inter. 2019;103(3):337–343. doi: 10.1159/000501529
  42. Sager C, Barroso UJr, Murillo J, et al. Management of neurogenic bladder dysfunction in children update and recommendations on medical treatment. Int Braz J Urol. 2022;48(1):31–51. doi: 10.1590/S1677-5538.IBJU.2020.098
  43. Humphreys MR, Vandersteen DR, Slezak JM, et al. Preliminary results of sacral neuromodulation in 23 children. J Urol. 2006;176(5):2227–2231. doi: 10.1016/j.juro.2006.07.013
  44. Routh JC, Cheng EY, Austin JC, et al. Design and methodological considerations of the centers for disease control and prevention urologic and renal protocol for the newborn and young child with spina bifida. J Urol. 2016;196(6):1728–1734. doi: 10.1016/j.juro.2016.07.081
  45. Van der Wilt AA, van Wunnik BPW, Sturkenboom R, et al. Sacral neuromodulation in children and adolescents with chronic constipation refractory to conservative treatment. International Journal of Colorectal Disease. 2016;31(8):1459–1466. doi: 10.1007/s00384-016-2604-8
  46. Lu PL, Koppen IJN, Orsagh-Yentis DK. Sacral nerve stimulation for constipation and fecal incontinence in children: long-term outcomes, patient benefit, and parent satisfaction. Neurogastroenterol Motil. 2017;30(2). doi: 10.1111/nmo.13184
  47. Koppen IJ, von Gontard A, Chase J, et al. Management of functional nonretentive fecal incontinence in children: recommendations from the International Children’s Continence Society. J Pediatr Urol. 2016;12(1):56–64. doi: 10.1016/j.jpurol.2015.09.008
  48. Sulkowski JP, Nacion KM, Deans KJ, et al. Sacral nerve stimulation: a promising therapy for fecal and urinary incontinence and constipation in children. J Pediatr Surg. 2015;50(10):1644–1647. doi: 10.1016/j.jpedsurg.2015.03.0
  49. Ramage L, Malakounides G, Iacona R. Current state of neuromodulation for constipation and fecal incontinence in children: a systematic review. European Journal of Pediatric Surgery. 2019;29(6):495–503. doi: 10.1055/s-0038-1677485
  50. Clark C, Ngo T, Comiter CV, et al. Sacral nerve stimulator revision due to somatic growth. J Urol. 2011;186:1576–1580. doi: 10.1016/j.juro.2011.03.098
  51. Boswell TC, Hollatz P, Hutcheson JC, et al. Device outcomes in pediatric sacral neuromodulation: a single center series of 187 patients. J Pediatr Urol. 2021;17(72):e1–e7. doi: 10.1016/j.jpurol.2020.10.010
  52. Siegel S, Kreder K, Takacs E, et al. Prospective randomized feasibility study assessing the effect of cyclic sacral neuromodulation on urinary urge incontinence in women. Female Pelvic Med Reconstr Surg. 2018;24(4):267–271. doi: 10.1097/SPV.0000000000000457
  53. Widmann B, Galata C, Warschkow R, et al. Success and complication rates after sacral neuromodulation for fecal incontinence and constipation: a single-center follow-up study. J Neurogastroenterol Motil. 2019;25(1):159–170. doi: 10.5056/jnm17106
  54. Stephany HA, Juliano TM, Clayton DB, et al. Prospective evaluation of sacral nerve modulation in children with validated questionnaires. J Urol. 2013;190(4):1516–1522. doi: 10.1016/j.juro.2013.01.099
  55. Wright AJ, Haddad M. Electroneurostimulation for the management of bladder bowel dysfunction in childhood. Eur J Paediatr Neurol. 2017;21(1):67–74. doi: 10.1016/j.ejpn.2016.05.012
  56. Sayed D, Chakravarthy K, Amirdelfan K, et al. ASPN MRI Compatibility Working Group. A comprehensive practice guideline for magnetic resonance imaging compatibility in implanted neuromodulation devices. Neuromodulation. 2020;23(7):893–911. doi: 10.1111/ner.13233
  57. Matzel KE, Chartier-Kastler E, Knowles CH, et al. Sacral neuromodulation: standardized electrode placement technique. Neuromodulation. 2017;20(8):816–824. doi: 10.1111/ner.12695

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2022 Khodorovskaya AM, Novikov VA, Zvosil AV, Umnov VV, Zharkov DS, Umnov DV, Vissarionov SV


 


Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».